Figure 1

Probability of survival of non-small-cell lung cancer patients with normal and elevated pretreatment serum CYFRA 21-1 level; Kaplan–Meier curves were constructed taking into account the whole population survival.
Probability of survival of non-small-cell lung cancer patients with normal and elevated pretreatment serum CYFRA 21-1 level; Kaplan–Meier curves were constructed taking into account the whole population survival.